Senti Biosciences Stock Investor Sentiment

SNTI Stock  USD 2.12  0.06  2.75%   
Under 62% of Senti Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that many traders are alarmed. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  

Senti Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at news.google.com         
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb...
Google News at Macroaxis
few days ago at news.google.com         
Senti Biosciences Faces Financial Challenges Amid Strategic Focus - TipRanks
Google News at Macroaxis
six days ago at seekingalpha.com         
Disposition of 137117 shares by New Enterprise Associates 15, L.p. of Senti Biosciences subject to R...
seekingalpha News
over a week ago at globenewswire.com         
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
Macroaxis News: globenewswire.com
over a week ago at news.google.com         
Intel says it lowered stakes in Astera Labs, Joby Aviation, Senti Biosciences - MSN
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Forbes Christopher of 17464 shares of Senti Biosciences at 2.77 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Farokhzad Omid of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Acquisition by Rajangam Kanya of 327750 shares of Senti Biosciences subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
Senti Bio to Participate in Upcoming Investor Conferences - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
Senti Biosciences Trading Up 5.2 percent - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
SNTI - Senti Biosciences, Inc. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at investorplace.com         
SNTI Stock Earnings Senti Biosciences Reported Results for Q2 2024
sbwire news
over three months ago at news.google.com         
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights...
Google News at Macroaxis
over three months ago at globenewswire.com         
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines fo...
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines fo...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Senti Biosciences that are available to investors today. That information is available publicly through Senti media outlets and privately through word of mouth or via Senti internal channels. However, regardless of the origin, that massive amount of Senti data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Senti Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Senti Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Senti Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Senti Biosciences alpha.

Senti Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Senti Biosciences Trading Up 5.2 percent - MarketBeat
08/29/2024
2
Acquisition by Rajangam Kanya of 327750 shares of Senti Biosciences subject to Rule 16b-3
09/18/2024
3
Acquisition by Farokhzad Omid of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
09/27/2024
4
Acquisition by Forbes Christopher of 17464 shares of Senti Biosciences at 2.77 subject to Rule 16b-3
10/04/2024
5
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
11/14/2024
6
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
11/20/2024

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios